Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

778
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
778
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

841
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
841
Acne Infection01:27

Acne Infection

47
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Transfer Learning and Monte Carlo Dropout for Uncertainty Informed NIRS-based Detection of Systemic Sclerosis Hand Perfusion Patterns.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa.

Journal of neurology·2025
Same author

The cell biology of Extracellular Vesicles: A jigsaw puzzle with a myriad of pieces.

Current opinion in cell biology·2025
Same author

Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).

Trials·2024
Same author

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML.

Cell death & disease·2023
Same author

COVID-19 lockdown negatively impacted on adherence to denosumab therapy: incidence of non-traumatic fractures and role of telemedicine.

Journal of endocrinological investigation·2022

Related Experiment Video

Updated: Mar 29, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.3K

ATOPIC DERMATITIS: MELATONIN AS POTENTIAL TREATMENT.

L Marseglia1, C Cuppari2, S Manti2

  • 1Neonatal and Pediatric Intensive Care Unit, Department of Pediatrics, University of Messina, Italy.

Journal of Biological Regulators and Homeostatic Agents
|December 5, 2015
PubMed
Summary

Oxidative stress contributes to atopic dermatitis (AD). Melatonin, an indolamine, may offer a novel therapeutic approach by reducing oxidative stress and improving skin barrier function in AD patients.

More Related Videos

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.8K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.8K

Related Experiment Videos

Last Updated: Mar 29, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.3K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.8K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.8K

Area of Science:

  • Dermatology and immunology, focusing on skin barrier function and inflammatory processes.

Background:

  • Atopic dermatitis (AD) is a chronic inflammatory skin condition linked to skin barrier defects and immune dysregulation.
  • While the Th1-Th2 immune response has been central to AD pathogenesis, oxidative stress is increasingly recognized as a key predisposing factor.
  • Current treatments for AD exist, but novel therapeutic strategies are continually being explored.

Purpose of the Study:

  • To explore the potential of melatonin as an alternative therapeutic agent for atopic dermatitis.
  • To investigate the role of the cutaneous melatoninergic system in counteracting AD-associated stressors.

Main Methods:

  • Review of existing literature on atopic dermatitis, oxidative stress, and melatonin's biological activities.
  • Analysis of the pleiotropic effects of melatonin, particularly its antioxidant and immunomodulatory properties.
  • Examination of the expression and function of the cutaneous melatoninergic system.

Main Results:

  • Melatonin exhibits antioxidant properties that can counteract the oxidative stress implicated in AD.
  • The cutaneous melatoninergic system is widely expressed and possesses pleiotropic activities relevant to skin health.
  • Melatonin may regulate immune responses and reduce inflammation associated with AD.
  • Melatonin's actions could potentially restore skin integrity and barrier function.

Conclusions:

  • Melatonin's multifaceted effects, including antioxidant and immunomodulatory actions, position it as a promising therapeutic candidate for atopic dermatitis.
  • Targeting oxidative stress with melatonin may offer a novel strategy to manage AD.
  • Further clinical investigation into melatonin's efficacy and safety for AD treatment is warranted.